Are exosomes FDA-cleared for aesthetic use?

What do people mean by “exosomes” in aesthetics?

In biology, exosomes are a type of extracellular vesicle involved in cell-to-cell signaling. In consumer and clinic marketing, “exosome” is often used more loosely for products promoted for skin appearance, hair-related goals, or as add-ons after microneedling or other procedures.

Those contexts are not interchangeable. A topical cosmetic-style product, a product applied after microneedling or other skin disruption, and an injected product raise different regulatory and safety questions. A study about “exosomes” in general does not automatically validate every product sold under that label.

What is the difference between FDA-approved and FDA-cleared?

For many drugs and biological products, approval — for biologics, often via a biologics license pathway — means the agency has reviewed evidence for safety, purity, and potency for a specific product and indicated use. Marketing a product as treating a disease or condition in humans generally implicates drug and biologic frameworks when the product and claims fit those definitions.

Clearance is language most often associated with certain medical devices, such as some 510(k) pathways. It is not a generic stamp that transfers to every substance used alongside a device. An FDA-cleared microneedling device does not automatically mean an accompanying exosome-labeled product is FDA-cleared or FDA-approved for aesthetic use.

Is “FDA-registered” the same as FDA-approved?

No. Facility registration, manufacturing slogans, and “compliant” or cGMP talking points are not the same as product approval or clearance for a specific aesthetic indication. Clinics and marketers sometimes blur these categories. Ask for the product-specific regulatory basis, not a facility brochure, and request the matching FDA record.

What does “investigational use” mean?

Some products may be studied under FDA oversight in clinical research, for example under an investigational framework. Investigational research is not the same as commercial marketing of an approved aesthetic treatment. If a provider describes a product as investigational, ask what documentation exists and whether the use being offered is research under appropriate oversight — or commercial promotion.

What has the FDA said about exosome products?

The U.S. Food and Drug Administration has publicly stated that there are currently no FDA-approved exosome products, and that as a general matter, exosome products intended to treat diseases or conditions in humans are regulated as drugs and biological products subject to premarket review and approval requirements.

FDA has also published consumer-facing alerts and safety communications about regenerative medicine products — including stem cell and exosome products — warning that misleading marketing can put patients at risk, and has described serious adverse events associated with unapproved products marketed as containing exosomes.

Regulatory status is product-, claim-, and use-specific and can change. If a clinic says an exosome product is “FDA-cleared for aesthetic use” or “FDA-approved to rejuvenate skin,” ask them to show the product-specific FDA authorization that matches the exact product, indication, and route they propose.

If a clinic uses a cleared microneedling device with an exosome product, is the exosome product cleared too?

Not automatically. Device clearance, if any, concerns the device and its indications — not a blanket authorization for every substance applied afterward. Ask how the clinic characterizes the exosome product's regulatory status separately from the device.

Are topical exosome cosmetics automatically FDA-approved?

Most cosmetics are not FDA-approved in the way drugs are; they are regulated under a different framework, and companies remain responsible for safety and labeling. A product's legal sale as a cosmetic is not proof it is FDA-approved to treat disease — or safe to inject. Route and claims matter, so confirm classification with a board-certified physician.

What should I ask a board-certified doctor before an “exosome facial”?

Ask for the exact product name, manufacturer, lot, and source. Ask whether the product is topical only, used after microneedling, or injected, because route matters. Ask what intended use and claims are being made, and whether the claim is “FDA-approved,” “FDA-cleared,” “FDA-registered,” or “studied” — those words are not synonyms.

Also ask what peer-reviewed evidence exists for that specific product and route rather than for “exosomes” as a category, what the known risks, unknowns, and established alternatives are, and who will manage complications and report adverse events. Before-and-after galleries and influencer testimonials are not regulatory clearance.